SCOPUS 정보 검색 플랫폼

Cancer Chemotherapy and Pharmacology

Volumn 61, Issue 6, 2008, Pages 1083-1084

Dermatitis after suspected imatinib-levothyroxine interaction in a patient with gastrointestinal stromal tumor

(5) Cholongitas, Evangelos a Pipili, Chrysoula a Katsogridakis, Konstadinos a Relos, Konstadinos a Dasenaki, Maria a

a General Hospital of Sitia (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CYTOCHROME P450 3A4; IMATINIB; LEVOTHYROXINE; METHYLPREDNISOLONE; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB;

AGED; CONTROLLED STUDY; DERMATITIS; DRUG WITHDRAWAL; FEVER; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; LETTER; PRIORITY JOURNAL; PRURITUS; RASH; SKIN BIOPSY;

AGED; ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; SKIN; THYROXINE;

EID: 41049095849 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s00280-007-0562-0 Document Type: Letter

Times cited : (3)

References (8)

1
- 1542350259
- Gastrointestinal stromal tumors (GISTs)
- Saund MS, Demetri GD, Ashley SW (2004) Gastrointestinal stromal tumors (GISTs). Curr Opin Gastroenterol 20:89-94
- (2004) Curr Opin Gastroenterol , vol.20 , pp. 89-94
- Saund, M.S.¹ Demetri, G.D.² Ashley, S.W.³

2
- 11144240030
- Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors
- Severino G, Chillotti C, De Lisa R, Del Zompo M, Ardau R (2005) Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. Ann Pharmacother 39:162-164
- (2005) Ann Pharmacother , vol.39 , pp. 162-164
- Severino, G.¹ Chillotti, C.² De Lisa, R.³ Del Zompo, M.⁴ Ardau, R.⁵

3
- 33750594066
- Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine
- 11
- de Groot JW, Links TP, van der Graaf WT (2006) Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine. Ann Oncol 17(11):1719-20
- (2006) Ann Oncol , vol.17 , pp. 1719-20
- De Groot, J.W.¹ Links, T.P.² Van Der Graaf, W.T.³

4
- 33750961647
- Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors
- 9
- Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, Morgan JA, Dychter SS, Larsen PR, Demetri GD, Alexander EK (2006) Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 145(9):660-4
- (2006) Ann Intern Med , vol.145 , pp. 660-4
- Desai, J.¹ Yassa, L.² Marqusee, E.³ George, S.⁴ Frates, M.C.⁵ Chen, M.H.⁶ Morgan, J.A.⁷ Dychter, S.S.⁸ Larsen, P.R.⁹ Demetri, G.D.¹⁰ Alexander, E.K.¹¹

5
- 25844471013
- Imatinib induces hypothyroidism in patients receiving levothyroxine
- de Groot JW, Zonnenberg BA, Plukker JT, Der Graaf WT, Links TP (2005) Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Pharmacol Ther 78:433-438
- (2005) Clin Pharmacol Ther , vol.78 , pp. 433-438
- De Groot, J.W.¹ Zonnenberg, B.A.² Plukker, J.T.³ Der Graaf, W.T.⁴ Links, T.P.⁵

6
- 0031785886
- Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes
- Liddle C, Goodwin BJ, George J, Tapner M, Farrell GC (1998) Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83:2411-2416
- (1998) J Clin Endocrinol Metab , vol.83 , pp. 2411-2416
- Liddle, C.¹ Goodwin, B.J.² George, J.³ Tapner, M.⁴ Farrell, G.C.⁵

7
- 0019799332
- A method for estimating the probability of adverse drug reactions
- Naranjo CA, Busto U, Sellers EM (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-45
- (1981) Clin Pharmacol Ther , vol.30 , pp. 239-45
- Naranjo, C.A.¹ Busto, U.² Sellers, E.M.³

8
- 23244433963
- Pharmacokinetics of imatinib mesylate in end stage renal disease. a case study
- Pappas P, Karavasilis V, Briasoulis E, Pavlidis N, Marselos M (2005) Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study. Cancer Chemother Pharmacol 56:358-360
- (2005) Cancer Chemother Pharmacol , vol.56 , pp. 358-360
- Pappas, P.¹ Karavasilis, V.² Briasoulis, E.³ Pavlidis, N.⁴ Marselos, M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.